Protagenic Therapeutics, Inc.new PTIX
OTC PTIX
$0.45 -0.02 (-4.66%)
As of: Nov 16, 2026 · 3:48 PM EST

Protagenic Therapeutics, Inc.new (PTIX) Liabilities and Shareholders Equity (2009 - 2026)

Updated

Protagenic Therapeutics, Inc.new (PTIX) posted Liabilities and Shareholders Equity of $2.27 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 54.6% from $5 million a year earlier and down 18.8% from the prior quarter.

Analysis

Protagenic Therapeutics, Inc.new (PTIX) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Protagenic Therapeutics, Inc.new's Liabilities and Shareholders Equity came in at $3.65 million.

  • Annual Liabilities and Shareholders Equity shows a five-year compound annual growth rate of -19.9% (FY2021 to FY2026).
  • In prior fiscal years, Protagenic Therapeutics, Inc.new's Liabilities and Shareholders Equity was $89,093 in FY2025, $1.96 million in FY2024 (-54.8%), $4.32 million in FY2023 (-46.2%) and $8.04 million in FY2022 (-27.3%).
  • The fiscal Q2 2027 figure stands as the lowest quarterly Liabilities and Shareholders Equity since fiscal Q4 2025.
  • According to Business Quant data, Liabilities and Shareholders Equity for the three prior fiscal quarters was $2.8 million (Q1 2027), $3.65 million (Q4 2026) and $4.43 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 197.43 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 147.68 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 119.92 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 51.41 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 205.00 Bn
10 Protagenic Therapeutics, Inc.new 850,797.76 -4.70 Mn - 2.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 2.27 Mn
Jun 30, 2026 2.80 Mn
Mar 31, 2026 3.65 Mn
Dec 31, 2025 4.43 Mn
Sep 30, 2025 5.00 Mn
Mar 31, 2025 89,093.00
Dec 31, 2024 1.96 Mn
Sep 30, 2024 1.51 Mn
Jun 30, 2024 1.47 Mn
Mar 31, 2024 2.58 Mn
Dec 31, 2023 4.32 Mn
Sep 30, 2023 5.43 Mn
Jun 30, 2023 6.92 Mn
Mar 31, 2023 7.67 Mn
Dec 31, 2022 8.04 Mn
Sep 30, 2022 8.25 Mn
Jun 30, 2022 9.01 Mn
Mar 31, 2022 9.80 Mn
Dec 31, 2021 11.06 Mn
Sep 30, 2021 11.66 Mn
API Access

Protagenic Therapeutics, Inc.new Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=PTIX&period=max&api_key=YOUR_API_KEY